KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$3.37
+0.91%
Mkt Cap $69.76M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
Implied Upside
+441.5%
Consensus $18.25 vs current $3.37
NASDAQ·Healthcare·Biotechnology
$3.37
+0.91%
Mkt Cap $69.76M
No recent rating data.
Price Target (5 analysts)
$18.25
Range $14.00 – $23.00
+441.5%
Consensus $18.25 vs current $3.37